V
This veterinary biotechnology company develops therapeutic systems for pets, focusing on first-in-class drug candidates targeting periodontitis, osteoarthritis, and gut motility disorders. By providing effective treatments, the company aims to enhance the health and quality of life for pets suffering from these common ailments.
Updated 2 months ago
Funding
$10.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- This veterinary biotechnology company develops therapeutic systems for pets, focusing on first-in-class drug candidates targeting periodontitis, osteoarthritis, and gut motility disorders. By providing effective treatments, the company aims to enhance the health and quality of life for pets suffering from these common ailments.